Skip to main content
PETS logo

PETS · Petmed Express Inc

Track PETS — free
$1.83 -0.21 (-10.10%) At close · Aug 14
Market Cap
$42.95M
Shares
21.68M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-08-13 PetMeds® Announces First Quarter Financial Results
2026-07-30 PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
2026-07-23 PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
2026-07-14 PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform
2026-06-30 PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
2026-06-02 PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
2026-05-29 PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
2026-04-22 PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
2025-12-11 PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
2025-12-10 PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
2025-11-26 PetMeds Extends Existing Shareholder Rights Plan
2025-11-13 PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq
2025-10-20 PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
2025-10-14 PetMeds® Files Form 10-K for Fiscal 2025
2025-10-08 PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Past events

Source: https://investors.petmeds.com/overview/default.aspx

Key facts CIK 1040130 CUSIP 716382106 13F (30d) 48 filings 47 filers Visit website Investor relations